Abstract
Lipoproteins are natural nanosized delivery vehicles within the circulatory system of all mammals. Scientists have long been interested in utilizing these endogenous macromolecules to transport exogenous imaging or therapeutic agents to specific cells or tissues in the body. The broad distribution of lipoprotein receptors throughout the body however has limited the utility of this approach for targeted delivery of medicinal agents. In recent years lipoprotein rerouting strategies have been developed wherein lipoproteins can be redirected from their natural lipoprotein receptors to an alternate receptor of choice. In this chapter we describe the basic methods of preparing folic acid-conjugated high-density lipoprotein nanoparticles for targeted delivery of imaging or chemotherapeutic agents to ovarian cancer cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zheng G, Chen J, Li H et al (2005) Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA 102:17757–17762
Lund-Katz S, Ibdah JA, Letizia JY et al (1988) A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. J Biol Chem 263:13831–13838
Chen J, Corbin IR, Li H et al (2007) Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc 129:5798–5799
Corbin IR, Chen J, Cao W et al (2007) Enhanced cancer-targeted delivery using engineered high-density lipoprotein-based nanocarriers. J Biomed Nanotechnol 3:367–376
Pittman RC, Glass CK, Atkinson D et al (1987) Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J Biol Chem 262:2435–2442
Kalli KR, Oberg AL, Keeney GL et al (2008) Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol 108:619–626
Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345–1353
Scanu A (1966) Forms of human serum high density lipoprotein protein. J Lipid Res 7:295–306
Lund-Katz S, Liu L, Thuahnai ST et al (2003) High density lipoprotein structure. Front Biosci 8:d1044–d1054
Wang ST, Andrusco R, Peter F (1987) A comparison of fatty acid composition of cholesteryl esters in subjects at various concentrations of serum lipid. Clin Biochem 20:31–35
Nikanjam M, Gibbs AR, Hunt CA et al (2007) Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. J Control Release 124:163–171
Corbin IR, Ng KK, Ding L, Jurisicova A, Zheng G (2013) Near Infrared Fluorescent Imaging of Metastatic Ovarian Cancer using Folate Receptor Targeted High-density Lipoprotein Nanocarriers. Nanomedicine (Lond) 8(6):875–890
Acknowledgement
This work was supported by the SW-SAIRP (U24 CA126608).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Corbin, I.R. (2013). Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery. In: Malek, A., Tchernitsa, O. (eds) Ovarian Cancer. Methods in Molecular Biology, vol 1049. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-547-7_35
Download citation
DOI: https://doi.org/10.1007/978-1-62703-547-7_35
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-546-0
Online ISBN: 978-1-62703-547-7
eBook Packages: Springer Protocols